← Leaderboards
Xu Yu
Massachusetts General Hospital
$21,799,579
Attributed
$25,674,873
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,674,873 · 13
By mechanism
R01$11,373,342 · 4
R37$4,345,711 · 1
R33$3,500,397 · 2
R61$3,415,661 · 1
R56$1,613,039 · 2
R21$1,426,723 · 3
Top collaborators
- Mathias Lichterfeld6 shared
- Shibani Mukerji3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Mathias Lichterfeld$34,368,889
- Jianren Mao$21,748,037
- Athe M. Tsibris$17,945,517
- Jodi Gilman$8,178,599
- A Eden Evins$20,295,171
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionHiv-1CellsViralImmune ResponseCharacteristicsImmuneMediatingInvestigationBaseIn VivoLeadT-LymphocyteImmunologicsDesignViremiaAnti-Retroviral AgentsCd8b1 GenePropertyCd4 Positive T LymphocytesPharmaceutical PreparationsPatient PopulationAffectGenes
Grant awards (43)
Elite controllers as a model for a cure of HIV-1 infection$861,601
R37 · FY2025 · AI · contact PI
Characterizing HIV-1 reservoirs in the central nervous system$707,024
R01 · FY2025 · MH · contact PI
Molecular profile of proviral reservoirs in HIV-infected drug users$975,058
R33 · FY2024 · DA · contact PI
Elite controllers as a model for a cure of HIV-1 infection$863,638
R37 · FY2024 · AI · contact PI
Characterizing HIV-1 reservoirs in the central nervous system$831,792
R01 · FY2024 · MH · contact PI
Elite controllers as a model for a cure of HIV-1 infection$865,633
R37 · FY2023 · AI · contact PI
Characterizing HIV-1 reservoirs in the central nervous system$834,714
R01 · FY2023 · MH · contact PI
Molecular profile of proviral reservoirs in HIV-infected drug users$986,339
R33 · FY2022 · DA · contact PI
Elite controllers as a model for a cure of HIV-1 infection$867,590
R37 · FY2021 · AI · contact PI
Molecular profile of proviral reservoirs in HIV-infected drug users$1,074,970
R61 · FY2020 · DA · contact PI
Elite controllers as a model for a cure of HIV-1 infection$887,249
R37 · FY2020 · AI · contact PI
Molecular profile of proviral reservoirs in HIV-infected drug users$168,000
R61 · FY2020 · DA · contact PI
Molecular profile of proviral reservoirs in HIV-infected drug users$1,076,786
R61 · FY2019 · DA · contact PI
A systems biology approach to fingerprint HIV immune defense in Elite Controllers$795,638
R01 · FY2019 · HL · contact PI
Molecular profile of proviral reservoirs in HIV-infected drug users$1,095,905
R61 · FY2018 · DA · contact PI
A systems biology approach to fingerprint HIV immune defense in Elite Controllers$809,660
R01 · FY2018 · HL · contact PI
Targeting HIV-1 persistence with Interferon-a$513,000
R33 · FY2018 · AI · contact PI
A systems biology approach to fingerprint HIV immune defense in Elite Controllers$823,340
R01 · FY2017 · HL · contact PI
Targeting HIV-1 persistence with Interferon-a$513,000
R33 · FY2017 · AI · contact PI
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection$435,000
R01 · FY2017 · AI · contact PI
A systems biology approach to fingerprint HIV immune defense in Elite Controllers$859,884
R01 · FY2016 · HL · contact PI
Targeting HIV-1 persistence with Interferon-a$513,000
R33 · FY2016 · AI · contact PI
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection$435,000
R01 · FY2016 · AI · contact PI
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection$435,000
R01 · FY2015 · AI · contact PI
T memory stem cell aging in HIV-1 infection$257,085
R21 · FY2015 · HL · contact PI
Targeting HIV-1 persistence with Interferon-a$239,250
R21 · FY2015 · AI · contact PI
A systems biology approach to fingerprint HIV immune defense in Elite Controllers$885,595
R56 · FY2014 · HL · contact PI
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection$435,000
R01 · FY2014 · AI · contact PI
Targeting HIV-1 persistence with Interferon-a$239,250
R21 · FY2014 · AI · contact PI
T memory stem cell aging in HIV-1 infection$217,500
R21 · FY2014 · HL · contact PI
A Microengraving Technology for the Study of Latently HIV-infected Primary Cells$380,568
R01 · FY2013 · AI · contact PI
A systems biology approach to fingerprint HIV immune defense in Elite Controllers$727,444
R56 · FY2012 · AI · contact PI
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection$432,507
R01 · FY2012 · AI · contact PI
A Microengraving Technology for the Study of Latently HIV-infected Primary Cells$405,590
R01 · FY2012 · AI · contact PI
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection$432,540
R01 · FY2011 · AI · contact PI
A Microengraving Technology for the Study of Latently HIV-infected Primary Cells$402,920
R01 · FY2011 · AI · contact PI
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection$436,943
R01 · FY2010 · AI · contact PI
A Microengraving Technology for the Study of Latently HIV-infected Primary Cells$426,909
R01 · FY2010 · AI · contact PI
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection$155,530
R01 · FY2010 · AI · contact PI
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection$449,764
R01 · FY2009 · AI · contact PI
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection$448,019
R01 · FY2008 · AI · contact PI
Functional Proteomics of HIV-1-Specific CD8+ T cells$254,888
R21 · FY2007 · AI · contact PI
Functional Proteomics of HIV-1-Specific CD8+ T cells$218,750
R21 · FY2006 · AI · contact PI